Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity

Published:2018-06-22 Issue:8 Volume:19 Page:541-550
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Casado JL¹^ORCID,Santiuste C¹,Vivancos MJ¹,Monsalvo M¹,Moreno A¹,Perez-Elías MJ¹,del Rey JM¹,Moreno S¹

Affiliation:

1. Department of Infectious Diseases and Biochemistry; Ramon y Cajal Hospital; Madrid Spain

Funder

The Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS)

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12630/fullpdf

Reference30 articles.

1. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients;Mocroft;AIDS,2010

2. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A: D study;Ryom;J Infect Dis,2013

3. Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy;Dauchy;Kidney Int,2011

4. Renal toxicity associated with tenofovir use;Rodriguez-Novoa;Expert Opin Drug Saf,2010

5. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir;Casado;AIDS,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study;Journal of Antimicrobial Chemotherapy;2020-03-05

2. Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV‐1‐infected patients: the TRILOBITHE pilot study;HIV Medicine;2019-05-26

3. Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?;European Journal of Clinical Microbiology & Infectious Diseases;2018-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3